Bladder metastasis from type 2 papillary renal cell carcinoma: A case report

Zeng,Qinsong; Luo,Shuhang; Chen,Linze; Chen,Lingwu; Chen,Junxing

doi:10.3892/ol.2023.13856

Bladder metastasis from type 2 papillary renal cell carcinoma: A case report

Authors:
- Qinsong Zeng
- Shuhang Luo
- Linze Chen
- Lingwu Chen
- Junxing Chen
View Affiliations

Affiliations: Department of Urology, The First Affiliated Hospital of Sun Yat‑Sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Urology, Da Lang Hospital of Dongguan, Dongguan, Guangdong 523777, P.R. China
Published online on: May 5, 2023 https://doi.org/10.3892/ol.2023.13856
Article Number: 270
Copyright: © Zeng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Renal cell carcinoma (RCC) is a common urinary tumor that may be pathologically divided into different subtypes: clear cell RCC, papillary RCC (PRCC) and chromophobe RCC. The most common organs of RCC metastasis are the lung, liver and bones, while bladder metastasis is rare. The treatment for PRCC metastasis is also a problem due to limited clinical data. Therefore, every single case of PRCC metastasis may significantly contribute to establishing a standard treatment protocol. The present study reported on a patient who suffered from repetitive bladder PRCC metastasis with 1.5 years of follow‑up. A 54‑year‑old male patient was diagnosed with left renal pelvic carcinoma in March 2020 and underwent a laparoscopic radical nephroureterectomy of the left kidney. The postoperative histological examination revealed that the tumor was consistent with a type 2 PRCC. Bladder metastasis was discovered three months after the surgery and transurethral resection of the bladder tumor (TURBT) was performed to eliminate the tumor in the bladder. Only three months after the initial TURBT, bladder metastasis was detected again, combined with lung metastasis. The patient refused to undergo radical cystectomy. Therefore, a second TURBT was arranged and targeted drugs were administered. However, both bladder and lung metastases were insensitive to the treatment strategy applied, although immunotherapy was subsequently added. The patient died in October 2021 due to respiratory failure and cachexia. The report aims to provide the whole treatment progress and lessons learned from this case, which is relatively rare.

View Figures

View References

1	Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, Grunwald V, Gillessen S and Horwich A; ESMO Guidelines Committee, : Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 30:706–720. 2019. View Article : Google Scholar : PubMed/NCBI
2	Siegel RL, Miller KD, Fuchs HE and Jemal A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022. View Article : Google Scholar : PubMed/NCBI
3	Flippot R, Comperat E, Tannir NM and Malouf GG: Papillary renal cell carcinoma: A family portrait. Eur Urol. 73:79–80. 2018. View Article : Google Scholar : PubMed/NCBI
4	Akhtar M, Al-Bozom IA and Al Hussain T: Papillary renal cell carcinoma (PRCC): An update. Adv Anat Pathol. 26:124–132. 2019. View Article : Google Scholar : PubMed/NCBI
5	Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S and Kiemeney LA: The epidemiology of renal cell carcinoma. Eur Urol. 60:615–621. 2011. View Article : Google Scholar : PubMed/NCBI
6	Thyavihally YB, Mahantshetty U, Chamarajanagar RS, Raibhattanavar SG and Tongaonkar HB: Management of renal cell carcinoma with solitary metastasis. World J Surg Oncol. 3:482005. View Article : Google Scholar : PubMed/NCBI
7	McAchran SE, Williams DH and MacLennan GT: Renal cell carcinoma metastasis to the bladder. J Urol. 184:726–727. 2010. View Article : Google Scholar : PubMed/NCBI
8	Liem EIML, Baard J, Cauberg ECC, Bus MTJ, de Bruin DM, Laguna Pes MP, de la Rosette JJMCH and de Reijke TM: Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette-Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer. Med Oncol. 34:1722017. View Article : Google Scholar : PubMed/NCBI
9	Matsumoto K, Hayakawa N, Nakamura S and Oya M: Bladder metastasis from renal cell carcinoma: Retrospective analysis of 65 reported cases. Clin Exp Metastasis. 32:135–141. 2015. View Article : Google Scholar : PubMed/NCBI
10	Gajasinghe DG, Nazeer I, Maddumage HP, Perera C and Abeygunasekera AM: Metachronous bladder metastases of a type 2 papillary renal cell carcinoma: A case report and review of the literature. World J Surg Oncol. 14:2192016. View Article : Google Scholar : PubMed/NCBI
11	Babar M, Hamdani S, Liu C, Vedula J and Schnapp DS: Metachronous renal cell carcinoma with metastasis to the urinary bladder, and distant organs, 28 years after radical nephrectomy: A case report. BMC Urol. 19:1362019. View Article : Google Scholar : PubMed/NCBI
12	Raviv S, Eggener SE, Williams DH, Garnett JE, Pins MR and Smith ND: Long-term survival after ‘drop metastases’ of renal cell carcinoma to the bladder. Urology. 60:6972002. View Article : Google Scholar : PubMed/NCBI
13	Chung HK, Silva LN, Pereira MA, Catelli R and Freitas RJ: Giant Abdominal Mass: Papillary Renal Cell Carcinoma with Metastases to the Bladder, Omentum and Perigastric tissue. J Surg Oncol. 2674–3000. 2020.
14	Hsieh PY, Hung SC, Li JR, Wang SS, Yang CK, Chen CS, Lu K, Cheng CL and Chiu KY: The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis. Urol Oncol. 39:422–430. 2021. View Article : Google Scholar : PubMed/NCBI
15	Abern MR, Owusu RA, Anderson MR, Rampersaud EN and Inman BA: Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: A systematic review and meta-analysis. J Natl Compr Canc Netw. 11:477–484. 2013. View Article : Google Scholar : PubMed/NCBI
16	Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME and Brady MS: Resection of metastatic renal cell carcinoma. J Clin Oncol. 16:2261–2266. 1998. View Article : Google Scholar : PubMed/NCBI
17	De Groote R, Larcher A, Goossens M, Hendrik R, Kris VS, De Coninck V, De Naeyer G, Schatteman P, D'Hondt F and Mottrie A: Metachronous metastasis of renal cell carcinoma to the urinary bladder: A case report. Ther Adv Urol. 10:29–32. 2017. View Article : Google Scholar : PubMed/NCBI
18	Motzer RJ, Hutson TE, Cella D, Reeves J, Hawkins R, Guo J, Nathan P, Staehler M, de Souza P, Merchan JR, et al: Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N Engl J Med. 369:722–731. 2013. View Article : Google Scholar : PubMed/NCBI
19	Kaelin WG Jr: The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer. 8:865–873. 2008. View Article : Google Scholar : PubMed/NCBI
20	D'Avella C, Abbosh P, Pal SK and Geynisman DM: Mutations in renal cell carcinoma. Urol Oncol. 38:763–773. 2020. View Article : Google Scholar : PubMed/NCBI
21	Sharma V, Miest TS, Juvet TS, Toussi A, Packiam V, Chamie K, Matin SF, Boorjian SA, Thompson RH, Frank I, et al: The impact of upper tract urothelial carcinoma diagnostic modality on intravesical recurrence after radical nephroureterectomy: A single institution series and updated meta-analysis. J Urol. 206:558–567. 2021. View Article : Google Scholar : PubMed/NCBI
22	Campbell MT, Matin SF, Tam AL, Sheth RA, Ahrar K, Tidwell RS, Rao P, Karam JA, Wood CG, Tannir NM, et al: Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma. Nat Commun. 12:63752021. View Article : Google Scholar : PubMed/NCBI